The tragedy of translation: the case of "first use" in human embryonic stem cell research.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21549323.
- Also identified by DOI 10.1016/j.stem.2011.04.009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Who should go first in phase-I human trials when neither risks nor benefits can be estimated? By assessing concerns raised by Bretzner et al. (2011), we highlight a tragic dimension underlying all such trials. We discuss strategies to avoid the pitfalls of ethical hubris by promoting fidelity and trust.
Medical subject headings
- Patient Selection
- Spinal Cord Injuries
- Stem Cell Transplantation